Simultaneous determination of free and total prostate-specific antigen by a magnetic particle-based time-resolved fluoroimmunoassay

被引:9
|
作者
Zhou, Bin [1 ]
Zhang, Jue [1 ]
Lv, Zhongwei [2 ]
Fan, Jun [1 ]
Zhang, Yi [1 ]
Huang, Biao [1 ]
机构
[1] Jiangsu Inst Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Dept Biotechnol,Key Lab Nucl Med, Wuxi, Jiangsu, Peoples R China
[2] Tongji Univ, Sch Med, Dept Nucl Med, Shanghai Peoples Hosp 10, Shanghai, Peoples R China
关键词
free and total prostate-specific antigen; magnetic nanoparticles; simultaneous detection; time-resolved fluoroimmunoassay; IMMUNOASSAY; CANCER; MEN;
D O I
10.1002/jcla.22137
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
ObjectivesIn this paper, a novel, sensitive and rapid method to simultaneously determine the free and total prostate-specific antigen (fPSA and tPSA) in serum by combining a time-resolved fluoroimmunoassay (TRFIA) and immunomagnetic separation was described. MethodsThe new approach uses magnetic particles as an immobilization matrix and means of separation, whereas the luminescent europium (Eu) and samarium (Sm) chelates are used as probes. The proposed method was evaluated via a single-step, sandwich-type TRFIA immunoassay of tPSA and fPSA as model analytes in serum. ResultsA new one-step method to simultaneously detect fPSA and tPSA in less than 15minutes was built up with the detection limits 0.006ng/mL for fPSA and 0.05ng/mL for tPSA. The assay ranges for fPSA and tPSA were both 0.5-100ng/mL, whereas the average recovery of those two obtained by our original mode were 95.9% and 95.3%, respectively. The present new TRFIA method carrying larger reproducibility, higher recovery, and sensitive specificity was demonstrated to be widely acceptable. ConclusionsThis simultaneous determination method containing a fast and sensitive approach can be put into an important position to screening large quantities of specimen, and be commonly applied to the clinical determination of fPSA and tPSA in human serum.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Highly sensitive and specific time-resolved fluoroimmunoassay (TR-FIA) of cyproterone acetate and free cyproterone
    Fiet, J
    Giton, F
    Boudi, A
    Boudou, P
    Vexiau, P
    Galons, H
    Raynaud, JP
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 75 (4-5) : 315 - 322
  • [22] Ultrasensitive immunoassay for free prostate-specific antigen based on ferrocenecarboxylate enhanced cathodic electrochemiluminescence of peroxydisulfate
    Zhang, Fei
    Mao, Li
    Zhu, Meiqiong
    MICROCHIMICA ACTA, 2014, 181 (11-12) : 1285 - 1291
  • [23] Digital droplet immunoassay based on a microfluidic chip with magnetic beads for the detection of prostate-specific antigen
    Zeng, Zhaokui
    Tian, Jingjing
    Ren, Zixuan
    Yang, Ying
    Gong, Qian
    Sun, Ruowei
    Zhang, Xun
    Liu, Wenfang
    Chen, Chuanpin
    JOURNAL OF SEPARATION SCIENCE, 2023, 46 (24)
  • [24] Editorial Comment to Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL
    Kitagawa, Yasuhide
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (08) : 609 - 610
  • [25] Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio
    Ferraro, Simona
    Biganzoli, Davide
    Rossi, Roberta Simona
    Palmisano, Franco
    Bussetti, Marco
    Verzotti, Enrica
    Gregori, Andrea
    Bianchi, Filippo
    Maggioni, Marco
    Ceriotti, Ferruccio
    Cereda, Cristina
    Zuccotti, Gianvincenzo
    Kavsak, Peter
    Plebani, Mario
    Marano, Giuseppe
    Biganzoli, Elia Mario
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (07) : 1327 - 1334
  • [26] Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen
    Ho, Matthew D.
    Yeo, Kiang-Teck J.
    Eggener, Scott E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (01) : 1 - 3
  • [27] Do Changes in a High Serum Prostate-Specific Antigen Level and the Free/Total Prostate-Specific Antigen Ratio after Antibiotic Treatment Rule Out Biopsy and the Suspicion of Cancer?
    Dirim, Ayhan
    Tekin, Mehmet Ilteris
    Koyluoglu, Eser
    Oguzulgen, Ahmet Ibrahim
    Peskircioglu, Levent
    Ozkardes, Hakan
    UROLOGIA INTERNATIONALIS, 2009, 82 (03) : 266 - 269
  • [28] The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
    Flores-Fraile, Maria-Carmen
    Padilla-Fernandez, Barbara Yolanda
    Valverde-Martinez, Sebastian
    Marquez-Sanchez, Magaly
    Garcia-Cenador, Maria-Begona
    Lorenzo-Gomez, Maria-Fernanda
    Flores-Fraile, Javier
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 14
  • [29] Association Between Glomerular Filtration Rate, Free, Total, and Percent Free Prostate-specific Antigen EDITORIAL COMMENT
    Christensson, Anders
    Lilja, Hans
    UROLOGY, 2010, 76 (05) : 1046 - 1047
  • [30] Serum-based ALYGNSA immunoassay for the prostate cancer biomarker, total prostate-specific antigen (tPSA)
    Brian C. Mackness
    Melisenda J. McDonald
    Analytical and Bioanalytical Chemistry, 2010, 397 : 3151 - 3154